Loading…
CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity
Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in me...
Saved in:
Published in: | PloS one 2015, Vol.10 (3), p.e0121140 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53 |
---|---|
cites | cdi_FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53 |
container_end_page | |
container_issue | 3 |
container_start_page | e0121140 |
container_title | PloS one |
container_volume | 10 |
creator | Jenkins, Molly H Brinckerhoff, Constance E Mullins, David W |
description | Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAFV600E. However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAFWT) and WM35 (BRAFV600E), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAFWT melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAFWT melanomas.
Expression of CXCR3 on BRAFWT melanoma cells may be a mediator of melanoma progression. |
doi_str_mv | 10.1371/journal.pone.0121140 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1667180947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3ea55b32632348fbae5e023ac0280b54</doaj_id><sourcerecordid>3633348691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53</originalsourceid><addsrcrecordid>eNp1UVtrFDEYDaLYWv0HogM-z5r7zLwI7WJ1YaFQKvoWvsl8M2aZSdZkVuy_N3WnpX3wKeHk3Mgh5C2jKyYq9nEXDtHDuNoHjyvKOGOSPiOnrBG81JyK54_uJ-RVSjtKlai1fklOuKqaupH6lFytf6yvRZHckL2cHwrni4vr88vvN8WEI_gwQYZsREiYis22rAv8s4-Ykgu-AN8V82EK0Q3onXXz7Wvyoocx4ZvlPCPfLj_frL-W26svm_X5trS5Oy07KlWlqtZqaXurWtbUtKW5nWTQUtlB30KfoZ5xJVFBpbGW2AveV6A0KnFG3h9992NIZvmLZJjWFatpI6vM2BwZXYCd2Uc3Qbw1AZz5B4Q4GIizsyMagaBUK7gWXMg6R6NCygVYynMHJbPXpyXt0E7YWfRzhPGJ6dMX736aIfw2UlRUcpYNPiwGMfw6YJr_U1keWTaGlCL2DwmMmrvR71XmbnSzjJ5l7x63exDdryz-Av7WqeA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1667180947</pqid></control><display><type>article</type><title>CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Jenkins, Molly H ; Brinckerhoff, Constance E ; Mullins, David W</creator><contributor>Chen, Suzie</contributor><creatorcontrib>Jenkins, Molly H ; Brinckerhoff, Constance E ; Mullins, David W ; Chen, Suzie</creatorcontrib><description>Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAFV600E. However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAFWT) and WM35 (BRAFV600E), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAFWT melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAFWT melanomas.
Expression of CXCR3 on BRAFWT melanoma cells may be a mediator of melanoma progression.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0121140</identifier><identifier>PMID: 25798946</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Cancer ; Carcinogenesis - metabolism ; Cell growth ; Cell Line, Tumor ; Cell migration ; Clinical trials ; Cotton ; Cotton, Norris ; CXCR3 protein ; Cytokines ; Deprivation ; Environmental stress ; Fibroblasts ; Humans ; Hypoxia ; Immunology ; Interleukin 8 ; Interleukin-8 - genetics ; Interleukin-8 - metabolism ; Ligands ; Lymph nodes ; Male ; Medical research ; Medicine ; Melanoma ; Melanoma - genetics ; Melanoma - metabolism ; Melanoma - pathology ; Metastases ; Metastasis ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Molecular modelling ; Mutation ; Penicillin ; Proto-Oncogene Proteins B-raf - genetics ; Proto-Oncogene Proteins B-raf - metabolism ; Receptors, CXCR3 - genetics ; Receptors, CXCR3 - metabolism ; Signal Transduction ; Signaling ; Survival ; Tumorigenesis ; Tumorigenicity</subject><ispartof>PloS one, 2015, Vol.10 (3), p.e0121140</ispartof><rights>2015 Jenkins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Jenkins et al 2015 Jenkins et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53</citedby><cites>FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1667180947/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1667180947?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4022,25752,27922,27923,27924,37011,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25798946$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Chen, Suzie</contributor><creatorcontrib>Jenkins, Molly H</creatorcontrib><creatorcontrib>Brinckerhoff, Constance E</creatorcontrib><creatorcontrib>Mullins, David W</creatorcontrib><title>CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAFV600E. However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAFWT) and WM35 (BRAFV600E), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAFWT melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAFWT melanomas.
Expression of CXCR3 on BRAFWT melanoma cells may be a mediator of melanoma progression.</description><subject>Animals</subject><subject>Cancer</subject><subject>Carcinogenesis - metabolism</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Clinical trials</subject><subject>Cotton</subject><subject>Cotton, Norris</subject><subject>CXCR3 protein</subject><subject>Cytokines</subject><subject>Deprivation</subject><subject>Environmental stress</subject><subject>Fibroblasts</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Immunology</subject><subject>Interleukin 8</subject><subject>Interleukin-8 - genetics</subject><subject>Interleukin-8 - metabolism</subject><subject>Ligands</subject><subject>Lymph nodes</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Melanoma</subject><subject>Melanoma - genetics</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Penicillin</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Proto-Oncogene Proteins B-raf - metabolism</subject><subject>Receptors, CXCR3 - genetics</subject><subject>Receptors, CXCR3 - metabolism</subject><subject>Signal Transduction</subject><subject>Signaling</subject><subject>Survival</subject><subject>Tumorigenesis</subject><subject>Tumorigenicity</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1UVtrFDEYDaLYWv0HogM-z5r7zLwI7WJ1YaFQKvoWvsl8M2aZSdZkVuy_N3WnpX3wKeHk3Mgh5C2jKyYq9nEXDtHDuNoHjyvKOGOSPiOnrBG81JyK54_uJ-RVSjtKlai1fklOuKqaupH6lFytf6yvRZHckL2cHwrni4vr88vvN8WEI_gwQYZsREiYis22rAv8s4-Ykgu-AN8V82EK0Q3onXXz7Wvyoocx4ZvlPCPfLj_frL-W26svm_X5trS5Oy07KlWlqtZqaXurWtbUtKW5nWTQUtlB30KfoZ5xJVFBpbGW2AveV6A0KnFG3h9992NIZvmLZJjWFatpI6vM2BwZXYCd2Uc3Qbw1AZz5B4Q4GIizsyMagaBUK7gWXMg6R6NCygVYynMHJbPXpyXt0E7YWfRzhPGJ6dMX736aIfw2UlRUcpYNPiwGMfw6YJr_U1keWTaGlCL2DwmMmrvR71XmbnSzjJ5l7x63exDdryz-Av7WqeA</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Jenkins, Molly H</creator><creator>Brinckerhoff, Constance E</creator><creator>Mullins, David W</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2015</creationdate><title>CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity</title><author>Jenkins, Molly H ; Brinckerhoff, Constance E ; Mullins, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Cancer</topic><topic>Carcinogenesis - metabolism</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Clinical trials</topic><topic>Cotton</topic><topic>Cotton, Norris</topic><topic>CXCR3 protein</topic><topic>Cytokines</topic><topic>Deprivation</topic><topic>Environmental stress</topic><topic>Fibroblasts</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Immunology</topic><topic>Interleukin 8</topic><topic>Interleukin-8 - genetics</topic><topic>Interleukin-8 - metabolism</topic><topic>Ligands</topic><topic>Lymph nodes</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Melanoma</topic><topic>Melanoma - genetics</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Penicillin</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Proto-Oncogene Proteins B-raf - metabolism</topic><topic>Receptors, CXCR3 - genetics</topic><topic>Receptors, CXCR3 - metabolism</topic><topic>Signal Transduction</topic><topic>Signaling</topic><topic>Survival</topic><topic>Tumorigenesis</topic><topic>Tumorigenicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jenkins, Molly H</creatorcontrib><creatorcontrib>Brinckerhoff, Constance E</creatorcontrib><creatorcontrib>Mullins, David W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jenkins, Molly H</au><au>Brinckerhoff, Constance E</au><au>Mullins, David W</au><au>Chen, Suzie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015</date><risdate>2015</risdate><volume>10</volume><issue>3</issue><spage>e0121140</spage><pages>e0121140-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAFV600E. However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAFWT) and WM35 (BRAFV600E), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAFWT melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAFWT melanomas.
Expression of CXCR3 on BRAFWT melanoma cells may be a mediator of melanoma progression.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>25798946</pmid><doi>10.1371/journal.pone.0121140</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2015, Vol.10 (3), p.e0121140 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1667180947 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Animals Cancer Carcinogenesis - metabolism Cell growth Cell Line, Tumor Cell migration Clinical trials Cotton Cotton, Norris CXCR3 protein Cytokines Deprivation Environmental stress Fibroblasts Humans Hypoxia Immunology Interleukin 8 Interleukin-8 - genetics Interleukin-8 - metabolism Ligands Lymph nodes Male Medical research Medicine Melanoma Melanoma - genetics Melanoma - metabolism Melanoma - pathology Metastases Metastasis Mice Mice, Inbred NOD Mice, SCID Molecular modelling Mutation Penicillin Proto-Oncogene Proteins B-raf - genetics Proto-Oncogene Proteins B-raf - metabolism Receptors, CXCR3 - genetics Receptors, CXCR3 - metabolism Signal Transduction Signaling Survival Tumorigenesis Tumorigenicity |
title | CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A00%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CXCR3%20signaling%20in%20BRAFWT%20melanoma%20increases%20IL-8%20expression%20and%20tumorigenicity&rft.jtitle=PloS%20one&rft.au=Jenkins,%20Molly%20H&rft.date=2015&rft.volume=10&rft.issue=3&rft.spage=e0121140&rft.pages=e0121140-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0121140&rft_dat=%3Cproquest_plos_%3E3633348691%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3710-d045757bc64cfc5b1980b038641ab04dafbaf80bf1254e5a76e84ef32f7a56e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1667180947&rft_id=info:pmid/25798946&rfr_iscdi=true |